Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;22(4):430-432.
doi: 10.1016/S1473-3099(21)00696-4. Epub 2021 Dec 8.

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom

Julio Croda  1 , Otavio T Ranzani  2
Affiliations

Booster doses for inactivated COVID-19 vaccines: if, when, and for whom

Julio Croda et al. Lancet Infect Dis. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JC reports having received grants from NIH, Sanofi, and Merck and personal fees from the Pan American Health Organization. OTR declares no competing interests.

References

    1. Mallapaty S. China's COVID vaccines have been crucial—now immunity is waning. Nature. 2021;598:398–399. - PubMed
    1. Zeng G, Wu Q, Pan H, et al. Immunogenicity and safety of a third dose of CoronaVac vaccine, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00681-2. published online Dec 7. - DOI - PMC - PubMed
    1. Yue L, Zhou J, Zhou Y, et al. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern. Emerg Microbes Infect. 2021 doi: 10.1080/22221751.2021.1996210. published online Oct 19. - DOI - PMC - PubMed
    1. Vacharathit V, Aiewsakun P, Manopwisedjaroen S, et al. CoronaVac induces lower neutralising activity against variants of concern than natural infection. Lancet Infect Dis. 2021;21:1352–1354. - PMC - PubMed
    1. Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205–1211. - PubMed